These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 25577299)

  • 1. Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma.
    Iezzi R; Pompili M; La Torre MF; Campanale MC; Montagna M; Saviano A; Cesario V; Siciliano M; Annicchiarico E; Agnes S; Giuliante F; Grieco A; Rapaccini GL; De Gaetano AM; Gasbarrini A; Bonomo L;
    Dig Liver Dis; 2015 Mar; 47(3):242-8. PubMed ID: 25577299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver Resection versus Radiofrequency Ablation plus Transcatheter Arterial Chemoembolization in Cirrhotic Patients with Solitary Large Hepatocellular Carcinoma.
    Saviano A; Iezzi R; Giuliante F; Salvatore L; Mele C; Posa A; Ardito F; De Gaetano AM; Pompili M;
    J Vasc Interv Radiol; 2017 Nov; 28(11):1512-1519. PubMed ID: 28734848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of combination therapies in the management of hepatocellular carcinoma: transarterial chemoembolization with radiofrequency ablation versus microwave ablation.
    Ginsburg M; Zivin SP; Wroblewski K; Doshi T; Vasnani RJ; Van Ha TG
    J Vasc Interv Radiol; 2015 Mar; 26(3):330-41. PubMed ID: 25534635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transarterial chemoembolization using drug eluting beads and subsequent percutaneous MR-guided radiofrequency ablation in the therapy of intermediate sized hepatocellular carcinoma.
    Hoffmann R; Rempp H; Syha R; Ketelsen D; Pereira PL; Claussen CD; Clasen S
    Eur J Radiol; 2014 Oct; 83(10):1793-8. PubMed ID: 25052871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Outcomes of Transarterial Chemoembolization Combined with Radiofrequency Ablation Versus Transarterial Chemoembolization Alone for Recurrent Hepatocellular Carcinoma After Surgical Resection.
    Song Q; Ren W; Fan L; Zhao M; Mao L; Jiang S; Zhao C; Cui Y
    Dig Dis Sci; 2020 Apr; 65(4):1266-1275. PubMed ID: 31312995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viable hepatocellular carcinoma around retained iodized oil after transarterial chemoembolization: radiofrequency ablation of viable tumor plus retained iodized oil versus viable tumor alone.
    Kim JH; Kim PN; Won HJ; Shin YM
    AJR Am J Roentgenol; 2014 Nov; 203(5):1127-31. PubMed ID: 25341154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE).
    Iezzi R; Cesario V; Siciliani L; Campanale M; De Gaetano AM; Siciliano M; Agnes S; Giuliante F; Grieco A; Pompili M; Rapaccini GL; Gasbarrini A; Bonomo L;
    Radiol Med; 2013 Jun; 118(4):555-69. PubMed ID: 23358819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small hepatocellular carcinoma: is radiofrequency ablation combined with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone for treatment?
    Shibata T; Isoda H; Hirokawa Y; Arizono S; Shimada K; Togashi K
    Radiology; 2009 Sep; 252(3):905-13. PubMed ID: 19567647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical outcomes of radiofrequency ablation combined with transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma: a single-center experience].
    Lin JJ; Wu W; Jiang XF; Jin XJ; Lu LJ; Bao LW
    Zhonghua Zhong Liu Za Zhi; 2013 Feb; 35(2):144-7. PubMed ID: 23714672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transarterial chemoembolization plus computed tomography-guided percutaneous radiofrequency ablation for small hepatocellular carcinoma in special locations].
    Guo YJ; Huang WS; Zhou B; Chen JW; Cai MY; Qian JS; Huang MS; Shan H; Zhu KS
    Zhonghua Yi Xue Za Zhi; 2013 Sep; 93(33):2627-30. PubMed ID: 24360041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertonic saline-enhanced radiofrequency versus chemoembolization sequential radiofrequency in the treatment of large hepatocellular carcinoma.
    El-Kady NM; Esmat G; Mahmoud EH; Darweesh SK; Mahmoud SH; Elagawy WA
    Eur J Gastroenterol Hepatol; 2013 May; 25(5):628-33. PubMed ID: 23325283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcatheter arterial chemoembolization combined with radiofrequency ablation delays tumor progression and prolongs overall survival in patients with intermediate (BCLC B) hepatocellular carcinoma.
    Yin X; Zhang L; Wang YH; Zhang BH; Gan YH; Ge NL; Chen Y; Li LX; Ren ZG
    BMC Cancer; 2014 Nov; 14():849. PubMed ID: 25409554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinomas 2-3 cm in diameter: transarterial chemoembolization plus radiofrequency ablation vs. radiofrequency ablation alone.
    Kim JW; Kim JH; Won HJ; Shin YM; Yoon HK; Sung KB; Kim PN
    Eur J Radiol; 2012 Mar; 81(3):e189-93. PubMed ID: 21353417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medium-sized (3.1-5.0 cm) hepatocellular carcinoma: transarterial chemoembolization plus radiofrequency ablation versus radiofrequency ablation alone.
    Kim JH; Won HJ; Shin YM; Kim SH; Yoon HK; Sung KB; Kim PN
    Ann Surg Oncol; 2011 Jun; 18(6):1624-9. PubMed ID: 21445671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus RF ablation alone: a prospective randomized trial.
    Peng ZW; Zhang YJ; Liang HH; Lin XJ; Guo RP; Chen MS
    Radiology; 2012 Feb; 262(2):689-700. PubMed ID: 22157201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of safety and efficacy for transcatheter arterial chemoembolization alone and plus radiofrequency ablation in the treatment of single branch portal vein tumor thrombus of hepatocellular carcinoma and their prognosis factors].
    Zhao M; Wang JP; Li W; Huang ZL; Zhang FJ; Fan WJ; Zhang L; Li XS; Pan CC; Wu PH
    Zhonghua Yi Xue Za Zhi; 2011 May; 91(17):1167-72. PubMed ID: 21756768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined treatment, TACE and RF ablation, in HCC: preliminary results.
    Gasparini D; Sponza M; Marzio A; Zanardi R; Bazzocchi M; Cemal Y
    Radiol Med; 2002; 104(5-6):412-20. PubMed ID: 12589262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transarterial chemoembolization versus surgery/radiofrequency ablation for recurrent hepatocellular carcinoma with or without microvascular invasion.
    Jin YJ; Lee JW; Lee OH; Chung HJ; Kim YS; Lee JI; Cho SG; Jeon YS; Lee KY; Ahn SI; Shin WY
    J Gastroenterol Hepatol; 2014 May; 29(5):1056-64. PubMed ID: 24372785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment strategy for early hepatocellular carcinomas: comparison of radiofrequency ablation with or without transcatheter arterial chemoembolization and surgical resection.
    Tashiro H; Aikata H; Waki K; Amano H; Oshita A; Kobayashi T; Tanimoto Y; Kuroda S; Tazawa H; Chayama K; Asahara T; Ohdan H
    J Surg Oncol; 2011 Jul; 104(1):3-9. PubMed ID: 21656523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy of chemoembolization and radiofrequency ablation for the treatment of hepatocellular carcinoma in the caudate lobe.
    Fujimori M; Takaki H; Nakatsuka A; Uraki J; Yamanaka T; Hasegawa T; Shiraki K; Takei Y; Yamakado K
    J Vasc Interv Radiol; 2012 Dec; 23(12):1622-8. PubMed ID: 23177108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.